Services of MTRC

14

Jun 2019

A syndicated report (>80 pages) includes the overview and statistics of 16 key innovation funding and coverage with evidence development schemes in seven European countries: Austria, Belgium, England, France, Germany, the Netherlands and Switzerland. The price of the report is €1600. Read more

10

Jun 2019

Director of MTRC will visit HTAi meeting in Cologne on the 19th of June 2019. Reach out to us at info@mtrconsult.com to schedule a meeting to discuss your reimbursement needs in Europe. Read more

10

Jun 2019

Newly released interviews cover topics of organization and financing of health care systems in the Czech Republic, the Netherlands, Spain, the role of HTA in Italy and clinical decision-making for the introduction of novel technologies in the Netherlands. Read more

10

Jun 2019

Descriptions are available as webinars or presentations in Acrobat PDF. They cover stakeholders, money flow, payment system, innovation funding, funding, and HTA landscape. Currently, overviews are available for 15 EU markets: Austria, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, Norway, Romania, Spain, Sweden, and Switzerland. In June-July we will add overviews for Belgium, Greece, the Netherlands, Poland, Russia, and Turkey. The price of presentation is 490 euros per country. Read more

29

May 2019

The report includes all published reimbursement decisions for IVD tests in 2018 in European countries with established frameworks for out-patient reimbursement laboratory tests (Belgium, France, Germany, Netherlands, Switzerland). Read more

28

May 2019

The report includes an overview of funding framework and all (as of May 2019) decisions from ultimate payers and decisions makers in England (NHS England, one CCG), Germany (G-BA), Netherlands (Zorginstituut Nederland), Norway (“New Methods” framework) and Switzerland (Federal Office of Public Health). More than 1000 decisions are included. Read more

17

May 2019

The report summarizes HTA landscape, role of HTA in reimbursement processes in individual countries, provides list of HTAs per country, HTA body and program, per type of technology. In total, 12 countries, 51 organizations and more than 850 reports are included. Sample pages are available for download. Read more

06

May 2019

We are happy to announce the launch of “Med Tech Market Access Academy” (www.a-marketaccess.com), a unique repository of online courses and seminars on European market access for medical devices and in-vitro diagnostic tests. Seminars are delivered as pre-recorded webinars and cover general introduction into market access, and country-specific overviews. We are launching the platform with 6 seminars (general introduction into market access, and reimbursement overviews in EU5) and expect to add 4-6 seminars each month. Read more

06

May 2019

We are happy to announce the start of the first Youtube channel dedicated to market access for medical devices, in-vitro diagnostic tests, and e-health solutions, “Market Access Insider”. In the first season of the program, we will weekly release videos of interviews with decision-makers, researchers, consultants, physicians and patient representatives on the topics of the payment system, health insurance, reimbursement pathways, health technology assessment and others in European countries. The first season will include interviews with experts from the Czech Republic, France, Germany, Italy, the Netherlands, and Spain. Read more

16

Nov 2018

MTRC is offering an opportunity to access 2019 market access retainer scheme using the discounted price during November-December 2018. The benefit to our clients of entering into this scheme is the forward planning of market access-related project activities and more effective budget management. Read more

08

Oct 2018

MTRC expands the coverage of EU countries with its core service of reimbursement analysis (procedure coding, payment model, reimbursement tariffs). Work is done by MTRC personnel, supported by local reimbursement experts. Contact us, if you want to learn more. Read more

04

Oct 2018

The article "Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model", published in Plos One presented the cost effectiveness of tissue engineered bovine tissue pericardium scaffold (CardioCel) for the repair of congenital heart defects in comparison with surgery using xenogeneic, autologous, and synthetic patches over a 40-year time horizon from the perspective of the UK National Health Service. Read more